methyldopa has been researched along with tiapamil hydrochloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, E; de Yebenes, JG; Mena, MA; Muradas, V; Reiriz, J | 1 |
| Neumann, NU | 1 |
| Bergman, H; El-Sayeh, HG; Rathbone, J; Soares-Weiser, K | 1 |
1 review(s) available for methyldopa and tiapamil hydrochloride
| Article | Year |
|---|---|
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
Topics: Adrenergic Uptake Inhibitors; Anti-Dyskinesia Agents; Antipsychotic Agents; Celiprolol; Disease Progression; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Humans; Methyldopa; Randomized Controlled Trials as Topic; Reserpine; Tetrabenazine; Tiapamil Hydrochloride | 2018 |
2 other study(ies) available for methyldopa and tiapamil hydrochloride
| Article | Year |
|---|---|
Pharmacokinetics of L-dopa in patients with Parkinson's disease.
Topics: Biotransformation; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Levodopa; Methyldopa; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Tiapamil Hydrochloride | 1987 |
[Drug therapy in tardive dyskinesia].
Topics: Diagnosis, Differential; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Lithium; Methyldopa; Parasympathomimetics; Pyridoxine; Tiapamil Hydrochloride; Tranquilizing Agents; Tryptophan | 1980 |